KNSA
NASDAQ · Biotechnology
Kiniksa Pharmaceuticals Inte
$57.13
+2.02 (+3.67%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+27.2% upside
Low Target
$47.11
Average Target
$72.69
High Target
$100.82
Current Price
$57.13
Current
$57.13
$57.13
Target
$72.69
$72.69
$47.11
$72.69 avg
$100.82
Scenario Analysis
Bear Case
$47.11
-17.5%
Low target
Base Case
$72.69
+27.2%
Avg target
Bull Case
$100.82
+76.5%
High target
Risk/Reward
4.4x
Highly favorable
Price in Context
52-Week High
$59.87
-4.6% from high
52-Week Low
$26.27
+117.5% from low
50-Day SMA
$42.51
+34.4% vs SMA
200-Day SMA
$35.71
+60.0% vs SMA
RSI (14)
68.7
Neutral
Target vs 52W High
$72.69
+21.4% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 78% | $257.58 | +10.2% |
| AMGN | Hold | 44 | 50% | $190.87 | -45.0% |
| GILD | Strong Buy | 39 | 82% | $362.68 | +188.2% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -6.6% |
| REGN | Buy | 38 | 71% | $76.80 | -87.6% |
| ALNY | Strong Buy | 37 | 76% | $102.31 | -64.5% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -32.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -39.1% |